Prognostic value of pulmonary hypertension in patients undergoing surgery for degenerative mitral valve disease with leaflet prolapse

Journal of Cardiac Surgery

Volumn 27, Issue 6, 2012, Pages 668-675

  Nozohoor, Shahab ^a   Hyllén, Snejana ^a   Meurling, Carl ^b   Wierup, Per ^a   Sjögren, Johan ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT;

ADULT; AGE; AGED; ARTICLE; ARTIFICIAL VENTILATION; CEREBROVASCULAR DISEASE; CLINICAL EVALUATION; DEGENERATIVE DISEASE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTRAAORTIC BALLOON PUMP; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MITRAL VALVE PROLAPSE; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PROGNOSIS; PULMONARY HYPERTENSION; REOPERATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; FORECASTING; HEART VALVE PROSTHESIS IMPLANTATION; HYPERTENSION, PULMONARY; INCIDENCE; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE PROLAPSE; POSTOPERATIVE PERIOD; PROGNOSIS; PULMONARY ARTERY; RETROSPECTIVE STUDIES; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 84870220473     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/jocs.12026     Document Type: Article

References (23)

1. Rosen SE, Borer JS, Hochreiter C, et al: Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol 1994; 74: 374-380.
2. Vahanian A, Baumgartner H, Bax J, et al: Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268.
3. Bonow RO, Carabello BA, Kanu C, et al: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation 2006; 114: e84-e231.
4. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al: Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: Rationale for optimizing surgical indications. Circulation 1999; 99: 400-405.
5. Grigioni F, Avierinos JF, Ling LH, et al: Atrial fibrillation complicating the course of degenerative mitral regurgitation: Determinants and long-term outcome. J Am Coll Cardiol 2002; 40: 84-92.
6. Enriquez-Sarano M, Schaff HV, Orszulak TA, et al: Congestive heart failure after surgical correction of mitral regurgitation. A long-term study. Circulation 1995; 92: 2496-2503.
7. Mohty D, Orszulak TA, Schaff HV, et al: Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation 2001; 104: I1-I7.
8. Barbieri A, Bursi F, Grigioni F, et al: Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: A multicenter long-term international study. Eur Heart J 2011; 32: 665-667.
9. Alexopoulos D, Lazzam C, Borrico S, et al: Isolated chronic mitral regurgitation with preserved systolic left ventricular function and severe pulmonary hypertension. J Am Coll Cardiol 1989; 14: 319-322.
10. Ghoreishi M, Evans CF, DeFilippi CR, et al: Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: Implications for timing of surgery. J Thorac Cardiovasc Surg 2011; 142: 1439-1452.
11. Goldstone AB, Chikwe J, Pinney SP, et al: Incidence, epidemiology, and prognosis of residual pulmonary hypertension after mitral valve repair for degenerative mitral regurgitation. Am J Cardiol 2011; 107: 755-760.
12. Carpentier A,: Cardiac valve surgery-The "French correction". J Thorac Cardiovasc Surg 1983; 86: 323-337.
13. Galie N, Hoeper MM, Humbert M, et al: Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009; 30: 2493-2537.
14. Zoghbi WA, Enriquez-Sarano M, Foster E, et al: American Society of Echocardiography: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. Eur J Echocardiogr 2003; 4: 237-261.
15. Lee KS, Abbas AE, Khandheria BK, et al: Echocardiographic assessment of right heart hemodynamic parameters. J Am Soc Echocardiogr 2007; 20: 773-782.
16. Dekker FW, de Mutsert R, van Dijk PC, et al: Survival analysis: time-dependent effects and time-varying risk factors. Kidney Int 2008; 74: 994-997.
17. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification. J Am Soc Echocardiogr 2005; 18: 1440-1463.
18. Nashef SA, Roques F, Michel P, et al: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
19. Edwards FH, Peterson ED, Coombs LP, et al: Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001; 37: 885-892.
20. Walls MC, Cimino N, Bolling SF, et al: Persistent pulmonary hypertension after mitral valve surgery: Does surgical procedure affect outcome J Heart Valve Dis 2008; 17: 1-9.
21. Thourani VH, Weintraub WS, Guyton RA, et al: Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: Effect of age and concomitant coronary artery bypass grafting. Circulation 2003; 108: 298-304.
22. Li M, Dumesnil JG, Mathieu P, et al: Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol 2005; 45: 1034-1040.
23. Enriquez-Sarano M, Akins CW, Vahanian A,: Mitral regurgitation. Lancet 2009; 373: 1382-1394.